During the past decade, North Metropolitan Health Service conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "North Metropolitan Health Service" are "Huntington Disease" (3 trials) and "Huntington's Disease" (2 trials). Many other conditions were trialed in "North Metropolitan Health Service" in a lesser frequency.

Most popular intervention types in "North Metropolitan Health Service" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "WVE-120101" (2 trials), "WVE-120102" (2 trials) and "WVE-003" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Metropolitan Health Service" are 5 trials for "All" genders.

Currently, there are NaN active trials in "North Metropolitan Health Service". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in North Metropolitan Health Service, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in North Metropolitan Health Service, 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".